These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31039820)

  • 1. Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD).
    Joudrey PJ; Kladney M; Cunningham CO; Bachhuber MA
    Addict Sci Clin Pract; 2019 May; 14(1):19. PubMed ID: 31039820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.
    Hagedorn HJ; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Wisdom JP; Harris AH
    Implement Sci; 2016 May; 11():64. PubMed ID: 27164835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
    Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
    J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.
    Del Re AC; Gordon AJ; Lembke A; Harris AH
    Addict Sci Clin Pract; 2013 Jul; 8(1):12. PubMed ID: 23835352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.
    Williams EC; Young JP; Achtmeyer CE; Hendershot CS
    J Subst Abuse Treat; 2016 Nov; 70():14-20. PubMed ID: 27692183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.
    Frost MC; Matson TE; Tsui JI; Williams EC
    Drug Alcohol Depend; 2019 Jan; 194():288-295. PubMed ID: 30469100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perspectives on alcohol use disorder pharmacotherapy and integration of treatment into primary care settings.
    Haley SJ; Pinsker EA; Gerould H; Wisdom JP; Hagedorn HJ
    Subst Abus; 2019; 40(4):501-509. PubMed ID: 30829127
    [No Abstract]   [Full Text] [Related]  

  • 8. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration.
    Taylor E; Timko C; Harris AHS; Yu M; Finlay AK
    Addict Sci Clin Pract; 2019 Jan; 14(1):1. PubMed ID: 30602392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care.
    Bernstein E; Guo N; Goto T; Rothberg MB
    J Gen Intern Med; 2021 Jul; 36(7):1989-1996. PubMed ID: 33515195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: Data from a national sample of treatment organizations.
    Knudsen HK; Roman PM
    Subst Abus; 2016; 37(1):230-7. PubMed ID: 25893539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing Patterns of Mental Health Care Use: The Role of Integrated Mental Health Services in Veteran Affairs Primary Care.
    Leung LB; Yoon J; Rubenstein LV; Post EP; Metzger ME; Wells KB; Sugar CA; Escarce JJ
    J Am Board Fam Med; 2018; 31(1):38-48. PubMed ID: 29330238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using clinical decision support through the electronic medical record to increase prescribing of high-dose parenteral thiamine in hospitalized patients with alcohol use disorder.
    Wai JM; Aloezos C; Mowrey WB; Baron SW; Cregin R; Forman HL
    J Subst Abuse Treat; 2019 Apr; 99():117-123. PubMed ID: 30797383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in pharmacotherapy for alcohol use disorder in the context of universal health care: a Swedish register study.
    Karriker-Jaffe KJ; Ji J; Sundquist J; Kendler KS; Sundquist K
    Addiction; 2017 Aug; 112(8):1386-1394. PubMed ID: 28406579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who receives treatment for alcohol use disorders in the European Union? A cross-sectional representative study in primary and specialized health care.
    Rehm J; Manthey J; Struzzo P; Gual A; Wojnar M
    Eur Psychiatry; 2015 Nov; 30(8):885-93. PubMed ID: 26647862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.
    Harris AH; Bowe T; Hagedorn H; Nevedal A; Finlay AK; Gidwani R; Rosen C; Kay C; Christopher M
    Addict Sci Clin Pract; 2016 Sep; 11(1):15. PubMed ID: 27633982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy.
    Dimitropoulos E; Bertucci S; Wong K
    Subst Abus; 2018; 39(2):190-192. PubMed ID: 29558338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population.
    Huskamp HA; Reif S; Greenfield SF; Normand ST; Busch AB
    J Gen Intern Med; 2020 Nov; 35(11):3262-3270. PubMed ID: 32754780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.